Skip to main content
OpenTrials

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,660 public trials 308 recruiting studies
Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Completed

A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

NCT05917509

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
View all 47 locations
View Trial Details
Completed

Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

NCT05551273

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +18 more
Locations
  • UCSD Antiviral Research Center CRS (Site 701) San Diego, California, United States
  • The Ponce de Leon Center CRS (Site 5802) Atlanta, Georgia, United States
  • Weill Cornell Chelsea CRS (Site 7804) New York, United States
  • Greensboro CRS (Site# 3203) Greensboro, North Carolina, United States
View Trial Details
Completed

Functional Interval Training for Veterans Exercising Through Telehealth.

NCT04103593

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Atlanta VA Medical and Rehab Center, Decatur, GA Decatur, Georgia, United States
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Baltimore, Maryland, United States
  • Salem VA Medical Center, Salem, VA Salem, Virginia, United States
View Trial Details
Completed

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

NCT05406583

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • USC - Maternal Child Adolescent/Adult Center Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA NICHD CRS Los Angeles, California, United States
  • University of Colorado Denver NICHD CRS Aurora, Colorado, United States
  • Emory University School of Medicine NICHD CRS Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Completed

Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

NCT01687192

Conditions
Autoimmune Diseases, Blood-Borne Infections, Communicable Diseases, +19 more
Locations
  • CHU de Bordeaux, Hôpital Pellegrin-Enfants Bordeaux, France
  • HCLyon, Hôpital Femme-mère-enfant Bron, France
  • CHU de Lille, Hôpital Jeanne de Flandres Lille, France
  • CHU de Montpellier, Hôpital Arnaud de Villeneuve Montpellier, France
View Trial Details

Related conditions